Stryker Corporation (SYK)
USD 359.17
(-3.14%)
USD 359.17
(-3.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.16 Billion USD | 16.76% |
| 2022 | 4.53 Billion USD | 12.2% |
| 2021 | 4.64 Billion USD | 23.17% |
| 2020 | 3.75 Billion USD | -20.8% |
| 2019 | 4.17 Billion USD | 17.21% |
| 2018 | 3.61 Billion USD | 0.85% |
| 2017 | 3.36 Billion USD | 8.26% |
| 2016 | 3.12 Billion USD | 6.25% |
| 2015 | 2.66 Billion USD | 75.49% |
| 2014 | 2.6 Billion USD | -2.11% |
| 2013 | 2.35 Billion USD | -30.21% |
| 2012 | 2.04 Billion USD | 2.5% |
| 2011 | 2.26 Billion USD | -4.58% |
| 2010 | 2.21 Billion USD | 16.61% |
| 2009 | 2.02 Billion USD | 8.82% |
| 2008 | 1.99 Billion USD | 17.43% |
| 2007 | 1.75 Billion USD | 10.05% |
| 2006 | 1.44 Billion USD | 12.61% |
| 2005 | 1.25 Billion USD | 8.81% |
| 2004 | 1.2 Billion USD | 34.81% |
| 2003 | 901 Million USD | 16.75% |
| 2002 | 750.8 Million USD | 19.41% |
| 2001 | 644.6 Million USD | 7.18% |
| 2000 | 599 Million USD | -18.83% |
| 1999 | 527.5 Million USD | 108.22% |
| 1998 | 242.1 Million USD | 71.89% |
| 1997 | 233.5 Million USD | 44.85% |
| 1996 | 168.9 Million USD | -20.81% |
| 1995 | 186 Million USD | 34.18% |
| 1994 | 141.4 Million USD | 29.13% |
| 1993 | 108.1 Million USD | 26.98% |
| 1992 | 85.1 Million USD | 33.17% |
| 1991 | 63.3 Million USD | 47.9% |
| 1990 | 42.8 Million USD | 12.63% |
| 1989 | 38 Million USD | 17.28% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.23 Billion USD | -22.37% |
| 2024 Q2 | 1.41 Billion USD | 6.25% |
| 2024 Q3 | 1.35 Billion USD | 3.36% |
| 2023 Q2 | 1.23 Billion USD | 23.99% |
| 2023 Q1 | 992 Million USD | -31.16% |
| 2023 Q4 | 1.51 Billion USD | 25.43% |
| 2023 Q3 | 1.21 Billion USD | -1.54% |
| 2023 FY | - USD | 16.76% |
| 2022 Q2 | 1.03 Billion USD | 44.07% |
| 2022 Q1 | 717 Million USD | -32.8% |
| 2022 FY | - USD | 12.2% |
| 2022 Q3 | 1.05 Billion USD | 1.65% |
| 2022 Q4 | 1.44 Billion USD | 37.24% |
| 2021 Q3 | 841 Million USD | -25.24% |
| 2021 FY | - USD | 23.17% |
| 2021 Q2 | 1.12 Billion USD | 50.6% |
| 2021 Q1 | 747 Million USD | -26.33% |
| 2021 Q4 | 1.06 Billion USD | 26.87% |
| 2020 FY | - USD | -20.8% |
| 2020 Q2 | 173 Million USD | -78.93% |
| 2020 Q3 | 1.06 Billion USD | 513.29% |
| 2020 Q4 | 1.01 Billion USD | -4.43% |
| 2020 Q1 | 821 Million USD | -29.53% |
| 2019 FY | - USD | 17.21% |
| 2019 Q1 | 744 Million USD | -17.33% |
| 2019 Q3 | 920 Million USD | -12.05% |
| 2019 Q2 | 1.04 Billion USD | 40.59% |
| 2019 Q4 | 1.16 Billion USD | 26.63% |
| 2018 Q2 | 862 Million USD | 11.23% |
| 2018 FY | - USD | 0.85% |
| 2018 Q1 | 775 Million USD | -13.79% |
| 2018 Q3 | 769 Million USD | -10.79% |
| 2018 Q4 | 900 Million USD | 17.04% |
| 2017 Q4 | 899 Million USD | 9.9% |
| 2017 FY | - USD | 8.26% |
| 2017 Q2 | 805 Million USD | 6.48% |
| 2017 Q1 | 756 Million USD | -17.83% |
| 2017 Q3 | 818 Million USD | 1.61% |
| 2016 Q3 | 689 Million USD | -1.71% |
| 2016 Q4 | 920 Million USD | 33.53% |
| 2016 Q1 | 659 Million USD | -7.96% |
| 2016 FY | - USD | 6.25% |
| 2016 Q2 | 701 Million USD | 6.37% |
| 2015 Q2 | 702 Million USD | 24.69% |
| 2015 Q1 | 563 Million USD | -0.18% |
| 2015 Q3 | 779 Million USD | 10.97% |
| 2015 Q4 | 716 Million USD | -8.09% |
| 2015 FY | - USD | 75.49% |
| 2014 Q1 | 232 Million USD | -56.72% |
| 2014 Q2 | 411 Million USD | 77.16% |
| 2014 Q4 | 564 Million USD | 1.62% |
| 2014 Q3 | 555 Million USD | 35.04% |
| 2014 FY | - USD | -2.11% |
| 2013 Q3 | 252 Million USD | -34.88% |
| 2013 FY | - USD | -30.21% |
| 2013 Q4 | 536 Million USD | 112.7% |
| 2013 Q1 | 484 Million USD | -12.32% |
| 2013 Q2 | 387 Million USD | -20.04% |
| 2012 Q3 | 600 Million USD | -2.28% |
| 2012 FY | - USD | 2.5% |
| 2012 Q1 | 635 Million USD | 0.0% |
| 2012 Q2 | 614 Million USD | -3.31% |
| 2012 Q4 | 552 Million USD | -8.0% |
| 2011 Q1 | 550.1 Million USD | -26.83% |
| 2011 Q4 | 635 Million USD | 9.41% |
| 2011 Q3 | 580.4 Million USD | 13.51% |
| 2011 Q2 | 511.3 Million USD | -7.05% |
| 2011 FY | - USD | -4.58% |
| 2010 Q2 | 552.2 Million USD | 1.1% |
| 2010 FY | - USD | 16.61% |
| 2010 Q3 | 580.2 Million USD | 5.07% |
| 2010 Q4 | 751.8 Million USD | 29.58% |
| 2010 Q1 | 546.2 Million USD | -10.41% |
| 2009 FY | - USD | 8.82% |
| 2009 Q2 | 471.8 Million USD | 1.75% |
| 2009 Q1 | 463.7 Million USD | -15.64% |
| 2009 Q4 | 609.7 Million USD | 13.12% |
| 2009 Q3 | 539 Million USD | 14.24% |
| 2008 Q4 | 549.7 Million USD | 22.21% |
| 2008 Q1 | 461.6 Million USD | 5.56% |
| 2008 FY | - USD | 17.43% |
| 2008 Q3 | 449.8 Million USD | -6.37% |
| 2008 Q2 | 480.4 Million USD | 4.07% |
| 2007 Q4 | 437.3 Million USD | -41.86% |
| 2007 Q3 | 752.2 Million USD | 76.57% |
| 2007 Q2 | 426 Million USD | 6.37% |
| 2007 Q1 | 400.5 Million USD | 4.95% |
| 2007 FY | - USD | 10.05% |
| 2006 FY | - USD | 12.61% |
| 2006 Q4 | 381.6 Million USD | 15.22% |
| 2006 Q3 | 331.2 Million USD | -10.27% |
| 2006 Q2 | 369.1 Million USD | -7.75% |
| 2006 Q1 | 400.1 Million USD | 10.8% |
| 2005 FY | - USD | 8.81% |
| 2005 Q3 | 303 Million USD | -8.51% |
| 2005 Q2 | 331.2 Million USD | 3.27% |
| 2005 Q1 | 320.7 Million USD | 7.8% |
| 2005 Q4 | 361.1 Million USD | 19.17% |
| 2004 FY | - USD | 34.81% |
| 2004 Q1 | 251.9 Million USD | -3.38% |
| 2004 Q3 | 378.9 Million USD | 34.74% |
| 2004 Q4 | 297.5 Million USD | -21.48% |
| 2004 Q2 | 281.2 Million USD | 11.63% |
| 2003 Q1 | 209.1 Million USD | -0.72% |
| 2003 Q3 | 214.2 Million USD | 0.14% |
| 2003 Q2 | 215.1 Million USD | 3.23% |
| 2003 Q4 | 262.6 Million USD | 21.48% |
| 2003 FY | - USD | 16.75% |
| 2002 Q2 | 183.9 Million USD | 7.84% |
| 2002 Q3 | 186.1 Million USD | 10.63% |
| 2002 Q4 | 209.4 Million USD | 2.5% |
| 2002 FY | - USD | 19.41% |
| 2002 Q1 | 171.4 Million USD | -5.32% |
| 2001 Q3 | 150.3 Million USD | -3.28% |
| 2001 FY | - USD | 7.18% |
| 2001 Q1 | 155.6 Million USD | -8.3% |
| 2001 Q2 | 155.3 Million USD | 1.17% |
| 2001 Q4 | 182.6 Million USD | 20.16% |
| 2000 FY | - USD | -18.83% |
| 2000 Q4 | 166.5 Million USD | 17.87% |
| 2000 Q3 | 140.7 Million USD | -2.0% |
| 2000 Q2 | 147.6 Million USD | -0.62% |
| 2000 Q1 | 145.5 Million USD | -9.15% |
| 1999 Q2 | 127.8 Million USD | -6.82% |
| 1999 Q3 | 125.6 Million USD | -4.39% |
| 1999 Q4 | 150.8 Million USD | -12.14% |
| 1999 FY | - USD | 108.22% |
| 1999 Q1 | 123.3 Million USD | 8.11% |
| 1998 Q2 | 58.9 Million USD | -2.63% |
| 1998 Q4 | 50.1 Million USD | 258.11% |
| 1998 FY | - USD | 71.89% |
| 1998 Q1 | 64.4 Million USD | 1.06% |
| 1998 Q3 | 57.4 Million USD | -4.68% |
| 1997 Q3 | 51.2 Million USD | -3.14% |
| 1997 FY | - USD | 44.85% |
| 1997 Q1 | 53.8 Million USD | 295.24% |
| 1997 Q2 | 52.7 Million USD | 2.21% |
| 1997 Q4 | 59.3 Million USD | 14.6% |
| 1996 FY | - USD | -20.81% |
| 1996 Q4 | 32.2 Million USD | -70.0% |
| 1996 Q3 | 44.2 Million USD | -2.78% |
| 1996 Q2 | 45.7 Million USD | -3.79% |
| 1996 Q1 | 46.8 Million USD | -8.92% |
| 1995 Q3 | 41.1 Million USD | -8.31% |
| 1995 Q4 | 51.4 Million USD | 24.18% |
| 1995 Q1 | 48.7 Million USD | 5.27% |
| 1995 Q2 | 44.9 Million USD | -9.6% |
| 1995 FY | - USD | 34.18% |
| 1994 FY | - USD | 29.13% |
| 1994 Q2 | 29.6 Million USD | 0.74% |
| 1994 Q3 | 34.7 Million USD | 24.82% |
| 1994 Q4 | 47.4 Million USD | 33.04% |
| 1994 Q1 | 29.8 Million USD | -9.93% |
| 1993 Q3 | 25.1 Million USD | -4.4% |
| 1993 Q1 | 26 Million USD | -1.95% |
| 1993 Q2 | 25.8 Million USD | -0.4% |
| 1993 FY | - USD | 26.98% |
| 1993 Q4 | 31.4 Million USD | 26.36% |
| 1992 Q3 | 19.5 Million USD | -11.48% |
| 1992 Q2 | 20.9 Million USD | 8.29% |
| 1992 Q4 | 26.3 Million USD | 38.38% |
| 1992 Q1 | 19.7 Million USD | -5.39% |
| 1992 FY | - USD | 33.17% |
| 1991 Q4 | 21.1 Million USD | 51.11% |
| 1991 FY | - USD | 52.23% |
| 1991 Q3 | 14.1 Million USD | -2.17% |
| 1991 Q1 | 14.2 Million USD | 35.29% |
| 1991 Q2 | 14 Million USD | 0.0% |
| 1990 Q4 | 11 Million USD | 17.24% |
| 1990 Q3 | 9.8 Million USD | -11.22% |
| 1990 Q2 | 10.2 Million USD | -14.78% |
| 1990 FY | - USD | 4.66% |
| 1990 Q1 | 11.6 Million USD | 22.34% |
| 1989 FY | - USD | 17.68% |
| 1989 Q3 | 9 Million USD | -10.2% |
| 1989 Q2 | 9.4 Million USD | -81.82% |
| 1989 Q1 | 53.9 Million USD | 151.58% |
| 1989 Q4 | 9.5 Million USD | 6.82% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 50.683% |
| Allurion Technologies Inc. | -69.03 Million USD | 7574.903% |
| Artivion, Inc. | 38.14 Million USD | -13428.394% |
| Avanos Medical, Inc. | 53.2 Million USD | -9599.248% |
| Butterfly Network, Inc. | -124.84 Million USD | 4233.158% |
| Butterfly Network, Inc. | -124.84 Million USD | 4233.158% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 948.314% |
| Boston Scientific Corporation | 3.45 Billion USD | -49.435% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | 34875.576% |
| CONMED Corporation | 182.18 Million USD | -2732.27% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | -191.921% |
| Paragon 28, Inc. | -36.61 Million USD | 14192.97% |
| Glaukos Corporation | -82.11 Million USD | 6383.794% |
| Globus Medical, Inc. | 418.23 Million USD | -1133.744% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | 30346.19% |
| Integer Holdings Corporation | 282.05 Million USD | -1729.404% |
| Medtronic plc | 9.05 Billion USD | 43.021% |
| Nevro Corp. | -78.31 Million USD | 6689.197% |
| Owlet, Inc. | -27.48 Million USD | 18871.145% |
| Penumbra, Inc. | 111.99 Million USD | -4507.307% |
| Vicarious Surgical Inc. | -69.19 Million USD | 7557.51% |
| Smith & Nephew plc | 979 Million USD | -427.068% |
| Sonendo, Inc. | -54.76 Million USD | 9521.56% |
| STERIS plc | 1.41 Billion USD | -265.334% |
| Vapotherm, Inc. | -34.35 Million USD | 15118.773% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | -110.707% |